SKI Market

Indian Indices

Sensex

85,220.60 545.52
( 0.64%)

Global Indices

Nasdaq

48,381.01 -101.93
(-0.21%)

Dow Jones

6,916.41 -10.33
(-0.15%)

Hang Seng

50,384.39 -142.53
(-0.28%)

Nikkei 225

9,931.38 -9.33
(-0.09%)

Forex

USD-INR

89.89 0.08
(0.09%)

EUR-INR

105.79 0.08
(0.08%)

GBP-INR

121.32 0.14
(0.12%)

JPY-INR

0.58 0.00
(0.34%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Indiamart Intermesh Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

542726

INE933S01016

373.1225766

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

INDIAMART

22.28

13497.08

EPS(TTM)

Face Value()

Div & Yield %

100.8

2.22

Back

Relonchem receives UK MHRA's marketing approval for two products

Nov 17,2025

Marksans Pharma announced that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for its following products from UK MHRA:

1. Mefenamic Acid 250 mg Film-Coated Tablets
2. Mefenamic Acid 500 mg Film-Coated Tablets

85,220.60 545.52 ( 0.64%)

48,381.01 -101.93 (-0.21%)

6,916.41 -10.33 (-0.15%)

50,384.39 -142.53 (-0.28%)

9,931.38 -9.33 (-0.09%)

89.89 0.08 (0.09%)

105.79 0.08 (0.08%)

121.32 0.14 (0.12%)

0.58 0.00 (0.34%)